These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3311705)

  • 1. [Pathogenesis of hyperoxalurias and calcium oxalate calculi in intestinal diseases].
    Müller G; Schütte W; Möller T
    Dtsch Z Verdau Stoffwechselkr; 1987; 47(3):105-12. PubMed ID: 3311705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnosis of intestinal oxalate hyperabsorption in patients with idiopathic recurrent calcium oxalate urinary calculi].
    Berg W; Haerting R; Bothor C; Meinig S; Eschholz A; Schulze HP
    Urologe A; 1990 May; 29(3):148-51. PubMed ID: 2382323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical and animal experiment studies on the pathogenetic significance of small intestine diseases and resections for urolithiasis].
    Schäfer F; Gutsche B
    Z Urol Nephrol; 1983 Jul; 76(7):433-7. PubMed ID: 6637170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperoxaluria in idiopathic calcium oxalate nephrolithiasis.
    Yendt ER
    Md Med J; 1988 Nov; 37(11):857-60. PubMed ID: 3185157
    [No Abstract]   [Full Text] [Related]  

  • 5. [Resorption of oxalic acid in calcium oxalate nephrolithiasis].
    Müller G; Schütte W; Berg W; Möller T
    Z Urol Nephrol; 1987 Jul; 80(7):391-4. PubMed ID: 3660960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnostic markers in calcium nephrolithiasis--current and traditional ideas with a new look].
    Hess B
    Schweiz Med Wochenschr; 1995 Dec; 125(51-52):2460-70. PubMed ID: 8571096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hyperoxaluria and renal calculi].
    Buño Soto A; Torres Jiménez R; García Puig J; Mateos Antón F
    Arch Esp Urol; 1996 Sep; 49(7):707-26. PubMed ID: 9020008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperoxaluria in patients with idiopathic calcium nephrolithiasis.
    Trinchieri A; Ostini F; Nespoli R; Rovera F; Zanetti G; Pisani E
    J Nephrol; 1998; 11 Suppl 1():70-2. PubMed ID: 9604817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of renal stone risk by potassium-magnesium citrate during 5 weeks of bed rest.
    Zerwekh JE; Odvina CV; Wuermser LA; Pak CY
    J Urol; 2007 Jun; 177(6):2179-84. PubMed ID: 17509313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intestinal hyperabsorption of oxalate in calcium oxalate stone formers: application of a new test with [13C2]oxalate.
    Hesse A; Schneeberger W; Engfeld S; Von Unruh GE; Sauerbruch T
    J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S329-33. PubMed ID: 10541257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nephrolithiasis in patients with intestinal diseases].
    Cirillo M; Iudici M; Marcarelli F; Laudato M; Zincone F
    G Ital Nefrol; 2008; 25(1):42-8. PubMed ID: 18264917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystallization properties in urine from calcium oxalate stone formers.
    Tiselius HG; Bek-Jensen H; Fornander AM; Nilsson MA
    J Urol; 1995 Sep; 154(3):940-6. PubMed ID: 7637098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin E therapy prevents hyperoxaluria-induced calcium oxalate crystal deposition in the kidney by improving renal tissue antioxidant status.
    Thamilselvan S; Menon M
    BJU Int; 2005 Jul; 96(1):117-26. PubMed ID: 15963133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minipump induced hyperoxaluria and crystal deposition in rats: a model for calcium oxalate urolithiasis.
    Marengo SR; Chen D; MacLennan GT; Resnick MI; Jacobs GH
    J Urol; 2004 Mar; 171(3):1304-8. PubMed ID: 14767338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperoxaluric calcium nephrolithiasis.
    Asplin JR
    Endocrinol Metab Clin North Am; 2002 Dec; 31(4):927-49. PubMed ID: 12474639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of a mineral water rich in calcium, magnesium and bicarbonate on urine composition and the risk of calcium oxalate crystallization.
    Siener R; Jahnen A; Hesse A
    Eur J Clin Nutr; 2004 Feb; 58(2):270-6. PubMed ID: 14749747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of a rat model for calcium oxalate crystal formation without severe renal damage in selected conditions.
    Yamaguchi S; Wiessner JH; Hasegawa AT; Hung LY; Mandel GS; Mandel NS
    Int J Urol; 2005 Mar; 12(3):290-8. PubMed ID: 15828958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mild tubular damage induces calcium oxalate crystalluria in a model of subtle hyperoxaluria: Evidence that a second hit is necessary for renal lithogenesis.
    Gambaro G; Valente ML; Zanetti E; Della Barbera M; Del Prete D; D'Angelo A; Trevisan A
    J Am Soc Nephrol; 2006 Aug; 17(8):2213-9. PubMed ID: 16790510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enteric and mild hyperoxaluria.
    Sutton RA; Walker VR
    Miner Electrolyte Metab; 1994; 20(6):352-60. PubMed ID: 7783697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absorptive hyperoxaluria: a new clinical entity--successful treatment with hydrochlorothiazide.
    Yendt ER; Cohanim M
    Clin Invest Med; 1986; 9(1):44-50. PubMed ID: 3955921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.